Evidence map›Paper›PMID 38312123›Full record

ArticleNeuropsychiatric disease and treatment2024

Association of

Ying Qin, Jingwen Zhao, Yong Yang, Yanjing Liu, Hui Xiang, Jingfeng Tong, Chengchen Huang

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ying QinDepartment of Psychiatry, the Second People's Hospital of Guizhou Province, Guiyang, 550004, People's Republic of China.
Jingwen ZhaoDepartment of Psychiatry, the Second People's Hospital of Guizhou Province, Guiyang, 550004, People's Republic of China.
Yong YangDepartment of Psychiatry, the Second People's Hospital of Guizhou Province, Guiyang, 550004, People's Republic of China.
Yanjing LiuDepartment of Psychiatry, the Second People's Hospital of Guizhou Province, Guiyang, 550004, People's Republic of China.
Hui XiangDepartment of Psychology, Guizhou Provincial People's Hospital, Guiyang, 550002, People's Republic of China.
Jingfeng TongShanghai Conlight Medical Laboratory, Co, Ltd, Shanghai, 200032, People's Republic of China.
Chengchen HuangShanghai Conlight Medical Laboratory, Co, Ltd, Shanghai, 200032, People's Republic of China.
Xian Yang Central Hospital · CNShanghai Medical Information Center · CNGuizhou Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We investigate the association of Patients and Methods: A total of 140 male patients diagnosed with schizophrenia who were treated with any single atypical antipsychotic between May 2020 and May 2022 were retrospectively included. Clinical symptoms were assessed using Positive and Negative Syndrome Scale (PANSS). All SNPs were typed using Agena Bioscience MassARRAY DNA mass spectrometry. Plasma concentrations of antipsychotics at week 3, 6 and 12 after treatment commence were analyzed using mass spectrometry. Results: For efficacy of atypical antipsychotics, we observed no significant difference between Conclusion: The assessment of the correlation of genetic polymorphisms of

Indexed as

asian male patientsatypical antipsychoticsHTR1Aplasma concentrationpolymorphismschizophrenia

Identifiers

PMID38312123
PMCPMC10838100
OpenAlexW4391363381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.